| 2025年年报 | 2025年中报 | 2024年年报 | 2024年中报 | |
|---|---|---|---|---|
| 营业收入(元) | ||||
| 创新药研发生产服务(元) | 2,197,538,428.91 | 1,236,374,906.63 | 1,883,689,679.19 | 1,027,537,535.96 |
| 原料药、中间体(元) | 6,165,062,498.12 | 3,603,269,929.28 | 8,651,388,172.77 | 4,704,422,720.91 |
| 制剂(元) | - | - | - | 679,555,972.19 |
| 药品(元) | 1,149,889,050.37 | 583,053,763.86 | 1,255,600,899.17 | - |
| 其他(元) | 215,633,388.51 | - | 165,835,078.05 | - |
| 营业成本(元) | ||||
| 创新药研发生产服务(元) | 1,203,340,190.87 | 691,834,266.25 | 1,110,257,836.30 | 615,605,748.01 |
| 原料药、中间体(元) | 5,331,116,675.73 | 3,109,793,898.97 | 7,356,549,134.43 | 3,941,420,000.51 |
| 制剂(元) | - | - | - | 269,812,695.57 |
| 药品(元) | 442,140,499.62 | 227,212,665.85 | 492,096,231.26 | - |
| 其他(元) | 188,812,794.05 | - | 147,342,987.07 | - |
| 毛利(元) | ||||
| 创新药研发生产服务(元) | 994,198,238.04 | 544,540,640.38 | 773,431,842.89 | 411,931,787.95 |
| 原料药、中间体(元) | 833,945,822.39 | 493,476,030.31 | 1,294,839,038.34 | 763,002,720.40 |
| 制剂(元) | - | - | - | 409,743,276.62 |
| 药品(元) | 707,748,550.75 | 355,841,098.01 | 763,504,667.91 | - |
| 其他(元) | 26,820,594.46 | - | 18,492,090.98 | - |
| 毛利率(%) | ||||
| 创新药研发生产服务(%) | 45.24 | 44.04 | 41.06 | 40.09 |
| 原料药、中间体(%) | 13.53 | 13.70 | 14.97 | 16.22 |
| 制剂(%) | - | - | - | 60.30 |
| 药品(%) | 61.55 | 61.03 | 60.81 | - |
| 其他(%) | 12.44 | - | 11.15 | - |
| 收入构成(%) | ||||
| 创新药研发生产服务(%) | 22.59 | 22.80 | 15.75 | 16.03 |
| 原料药、中间体(%) | 63.37 | 66.45 | 72.36 | 73.37 |
| 制剂(%) | - | - | - | 10.60 |
| 药品(%) | 11.82 | 10.75 | 10.50 | - |
| 其他(%) | 2.22 | - | 1.39 | - |
| 毛利构成(%) | ||||
| 创新药研发生产服务(%) | 38.79 | 39.07 | 27.14 | 25.99 |
| 原料药、中间体(%) | 32.54 | 35.40 | 45.43 | 48.15 |
| 制剂(%) | - | - | - | 25.86 |
| 药品(%) | 27.62 | 25.53 | 26.79 | - |
| 其他(%) | 1.05 | - | 0.65 | - |